Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -24.46-22.972.447.39-57.36

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -24.46 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-24.46
Mar2023-22.97
Mar20222.44
Mar20217.39
Mar2020-57.36

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44
-66.98
Mar2021 7.39
Positive
Mar2020 -57.36 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹238.8 Cr -2.3% -6.6% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr 3.7% 3.7% -13.6% Stock Analytics
DIVIS LABORATORIES ₹162,538.0 Cr 7.3% 1.5% 7.3% Stock Analytics
CIPLA ₹120,737.0 Cr 0.8% -2.5% -8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,723.0 Cr -1.6% -1% 4% Stock Analytics
DR REDDYS LABORATORIES ₹103,025.0 Cr 2.1% -1.5% -7.3% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-2.3%

-6.6%

-0.2%

SENSEX

1.9%

1.3%

-0.9%


You may also like the below Video Courses